Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
What's up at stealthy Calico Labs? AI star Daphne Koller makes an abrupt exit as top team shrinks
8 years ago
People
AI
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
8 years ago
R&D
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
8 years ago
R&D
With Restasis in its crosshairs, Mylan adds a Botox biosim with Revance; Vertex starts second PhIII triple combo CF ...
8 years ago
News Briefing
Watch out Endo: Sorrento is after your $1B+ drug with FDA OK of ZTlido
8 years ago
Pharma
Novartis wants to be a leader in a new generation of prescription digital med programs, pairs with Pear
8 years ago
R&D
Pharma
It’s official: EMA to move into permanent Amsterdam premises in November ‘19 amid continued protests from Italy
8 years ago
Pharma
Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog the pack in microbiome R&D
8 years ago
Financing
PureTech's Gelesis brings in $30M to back its FDA pitch on a new weight loss therapy with troublesome data
8 years ago
Financing
Sucking up talent out of Novartis, a booming Rubius adds another $100 million mega-round to the kitty
8 years ago
Financing
Scopia snags two board seats at Acorda following stock purchase; BeiGene nabs second indication for Revlimid in China
8 years ago
News Briefing
Sentencing date looming, a federal judge's ruling could leave Martin Shkreli in prison for years to come
8 years ago
People
On this Rare Disease Day, let's all commit to helping recognize the life and work of biotech giant Henri A. Termeer
8 years ago
Biotech Voices
Armed with published animal data, gene-editing pioneer Intellia maps the road to an IND
8 years ago
Discovery
Novo Holdings is looking for a few good superbug biotechs in need of early-stage funding — investing $165M
8 years ago
Financing
Dialing down the toxic effects of radiation on cancer patients, Galera gets breakthrough status on Phase IIb data
8 years ago
R&D
Startup making Cas9 proxy for gene editing gets $55M to develop tools/software
8 years ago
Financing
AstraZeneca spins out 6 drugs and an R&D group into Viela Bio, which emerges with a pivotal program and $250M
8 years ago
Financing
Celgene shaken again after the FDA kicks back their marketing application on blockbuster hopeful ozanimod
8 years ago
R&D
Exelixis/Daiichi Sankyo ask Japanese regulators for green light on hypertension drug; Bristol-Myers Squibb licenses ...
8 years ago
News Briefing
Novartis’ oncology research chief in China jumps to upstart EpimAb in Shanghai
8 years ago
People
China
J&J collaborates with Aldeyra on new drugs for systemic inflammatory diseases
8 years ago
R&D
Pharma
Dana-Farber’s Laurie Glimcher helps launch a NYC biotech upstart with some key insights on immuno-oncology tech
8 years ago
Financing
Startups
Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral ...
8 years ago
Financing
Startups
First page
Previous page
1062
1063
1064
1065
1066
1067
1068
Next page
Last page